Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix
Condition(s):Cervical Cancer; Uterine CancerLast Updated:July 7, 2014Terminated
Hide Studies Not Open or Pending
Condition(s):Cervical Cancer; Uterine CancerLast Updated:July 7, 2014Terminated
Condition(s):Cervical Cancer; Precancerous ConditionLast Updated:January 28, 2010Completed
Condition(s):Cervix CancerLast Updated:November 2, 2007Unknown status
Condition(s):Papillomavirus Infections; Dysplasia; Cervix CancerLast Updated:August 28, 2019Completed
Condition(s):Uterine Cervical NeoplasmsLast Updated:June 19, 2015Completed
Condition(s):Cervix Cancer; Endometrial Cancer; Epithelial Ovarian CancerLast Updated:August 14, 2023Recruiting
Condition(s):HPV Infection; Cervix Cancer; Cervical DysplasiaLast Updated:February 22, 2024Completed
Condition(s):Cervical Adenocarcinoma; Cervical Adenosquamous Carcinoma; Cervical Squamous Cell Carcinoma; Recurrent Cervical Carcinoma; Stage IVB Cervical CancerLast Updated:October 17, 2018Completed
Condition(s):Neoplasms, Uterine Cervix; Cervical CancerLast Updated:April 30, 2012Completed
Condition(s):Cervix CarcinomaLast Updated:September 26, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.